0001315863-17-000343.txt : 20170410 0001315863-17-000343.hdr.sgml : 20170410 20170410132235 ACCESSION NUMBER: 0001315863-17-000343 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20170410 DATE AS OF CHANGE: 20170410 EFFECTIVENESS DATE: 20170410 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RPS BioPharma Investments, LP CENTRAL INDEX KEY: 0001702586 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-284414 FILM NUMBER: 17752681 BUSINESS ADDRESS: STREET 1: 190 ELGIN AVENUE CITY: GEORGE TOWN STATE: E9 ZIP: KY1-9001 BUSINESS PHONE: 212-883-0200 MAIL ADDRESS: STREET 1: 110 EAST 59TH STREET STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0707 D LIVE 0001702586 RPS BioPharma Investments, LP 27 HOSPITAL ROAD GEORGE TOWN E9 CAYMAN ISLANDS KY1-9008 212-883-0200 CAYMAN ISLANDS None None Other a Cayman Islands exempted limited partnership true 2016 Pablo Legorreta 110 East 59th Street 33rd Floor New York NY NEW YORK 10022 Director Director of the General Partner Rory Riggs 110 East 59th Street 33rd Floor New York NY NEW YORK 10022 Director Director of the General Partner N/A Pharma Management (Cayman) Ltd. Walker House, PO Box 908GT Mary Street Grand Cayman E9 CAYMAN ISLANDS KY1-9002 Promoter Pharma Management (Cayman) Ltd. is the General Partner of the Issuer Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b 3C 3C.7 false 2017-03-27 false true true true Structured in part as a business combination (exchange offer). 100000 Indefinite 164460793 Indefinite false 57 0 0 0 false RPS BioPharma Investments, LP /s/Pablo Legorreta Pablo Legorreta Director of the General Partner 2017-04-10